Brosius Mark's Form 4/A amendment
AmendedIntuitive Surgical Inc (ISRG) · filed Dec 17, 2025
- Accession no.
- 0001610717-25-000418
- Filed
- Dec 17, 2025
- Trade date
- Dec 12, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
- Original filed
- Dec 15, 2025
This filing lists 1 non-derivative transaction. It carries over 3 transactions from the original filing that it did not restate. Open-market sales total $425.3K. It was filed 5 days after the trade.
This amendment restates part of 0002010300-25-000004 (filed Dec 15, 2025). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brosius MarkCIK 0002010300 | Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Common Stock | SSaleDisposed | −312 | $547.36F2 | −$170,776.32 | 595 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0002010300-25-000004 (filed Dec 15, 2025).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Common Stock | MOption exerciseAcquired | +4,500 | $79.64 | +$358,380 | 5,407 | Direct | |
| Dec 15, 2025 | Common Stock | SSaleDisposed | −464 | $548.49 | −$254,499.36 | 443 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Common Stock | MOption exerciseDisposed | −4,500 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.
- F2
The third transaction line in Table I of the Form 4 filed by the Reporting Person on 12/15/2025 incorrectly reported the transaction details. The transaction line as reported herein has been restated to correct the errors in the original Form 4. Except as otherwise noted in this footnote, all other information disclosed in the Reporting Person's original Form 4 was accurately reported.
Referenced by the price of 1 transaction in Table I.
Remarks
SVP & Chief Mfg and Supply Chain Officer